ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ACHC vs CELC // EV/EBITDA & P/E VALUATION

Acadia Healthcare Company Inc. (NASDAQ) VS. Celcuity Inc. (NASDAQ) • 15-METRIC TALLY: ACHC 2 — CELC 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACHC VS. CELC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ACHC CELC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -24.80% -35.00% +10.20 ACHC /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -16.04% -4.53% -11.51 CELC /fcf-yield <GO>
Operating Margin -40.60% — — TIE /operating-margins <GO>
Net Profit Margin -33.30% — — TIE /net-margins <GO>
Revenue Growth (YoY) 5.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 ACHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.3 49.3 -1.99 CELC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.07 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 21.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.74B $3.39B -$648.2M CELC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ACHC REV CELC REV ACHC GROSS % CELC GROSS % ACHC FCF CELC FCF
FY 2025 $3.31B $0 — — -$439.9M -$153.5M
FY 2024 $3.15B $0 — — -$560.7M -$83.7M
FY 2023 $2.93B $0 — — $330.5M -$53.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACHC // BETA 1.07
CELC // BETA —